Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,022 | -1,145 | -229 | N/A |
| Depreciation Amortization | 5 | N/A | N/A | N/A |
| Accounts receivable | -245 | -19 | -10 | N/A |
| Accounts payable and accrued liabilities | 2,149 | 50 | 81 | N/A |
| Other Working Capital | 1,900 | 26 | 71 | N/A |
| Other Operating Activity | -1,196 | 223 | -62 | 0 |
| Operating Cash Flow | $-4,409 | $-865 | $-149 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -22,000 | N/A | N/A | N/A |
| PPE Investments | -63 | -2 | N/A | N/A |
| Investing Cash Flow | $-22,063 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 36,785 | 991 | 295 | N/A |
| Financing Cash Flow | $36,785 | $991 | $295 | $N/A |
| Beginning Cash Position | 270 | 146 | N/A | N/A |
| End Cash Position | 10,583 | 270 | 146 | N/A |
| Net Cash Flow | $10,313 | $124 | $146 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,409 | -865 | -149 | N/A |
| Capital Expenditure | -63 | -2 | N/A | N/A |
| Free Cash Flow | -4,472 | -867 | -149 | 0 |